NASDAQ · Medical - Diagnostics & Research
RadNet, Inc. (RDNT) Stock
$70.91
+3.96%
NASDAQ: RDNT
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call
GlobeNewswire · Jul 22, 2026
RDNT: Lowering target price to $59.00
Argus Research · Jul 22, 2026
3 Cash-Burning Stocks with Open Questions
StockStory · Jul 21, 2026
How RadNet’s (RDNT) AI Reporting Tools Could Improve Imaging Center Scale and Workflow
Insider Monkey · Jul 7, 2026
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
MT Newswires · Jun 25, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held9.97%
Institutions Held100.65%
Institutions Float Held111.79%
Peer Comparison
About RadNet, Inc.
RadNet, Inc. (RDNT) stock trades at $70.91 with a market capitalization of $5.58B. The stock is valued at a price-to-earnings (P/E) ratio of -265.10, price-to-book of 5.01, price-to-sales of 2.45. Over the past 52 weeks the stock has ranged between $50.82 and $85.84, and currently trades 17.4% below its 52-week high.
On profitability, RadNet, Inc. generates a return on equity (ROE) of -1.95%, return on capital employed of 2.57%, an operating margin of -3.45%, a net profit margin of -0.93%.